Q6TMG5 (NEMO_RAT) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 63.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: NF-kappa-B essential modulator Short name=NEMO Alternative name(s): IkB kinase-associated protein 1 Short name=IKKAP1 Inhibitor of nuclear factor kappa-B kinase subunit gamma Short name=I-kappa-B kinase subunit gamma Short name=IKK-gamma Short name=IKKG Short name=IkB kinase subunit gamma NF-kappa-B essential modifier | ||||
| Gene names |
| ||||
| Organism | Rattus norvegicus (Rat) [Reference proteome] | ||||
| Taxonomic identifier | 10116 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus![]() |
Protein attributes
| Sequence length | 412 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Function | Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Its binding to scaffolding polyubiquitin seems to play a role in IKK activation by multiple signaling receptor pathways. Also considered to be a mediator for TAX activation of NF-kappa-B. Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3. Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination By similarity. |
| Subunit structure | Homodimer; disulfide-linked. Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex. The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65. Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Interacts with COPS3, CYLD, NALP2, TRPC4AP and LRDD. Interacts with ATM; the complex is exported from the nucleus. Interacts with TRAF6. Interacts with TANK; the interaction is enhanced by IKBKE and TBK1. Part of a ternary complex consisting of TANK, IKBKB and IKBKG By similarity. Interacts with ZFAND5. Interacts with TNIP1 and TNFAIP3; TNIP1 facilitates the TNFAIP3-mediated de-ubiquitination of IKBKG. Interacts with TNFAIP3; the interaction is induced by TNF stimulation and by polyubiquitin. Interacts with NLRP10 By similarity. |
| Subcellular location | |
| Domain | The leucine-zipper domain and the C2HC-type zinc-finger are essential for polyubiquitin binding and for the activation of IRF3 By similarity. |
| Post-translational modification | Phosphorylation at Ser-68 attenuates aminoterminal homodimerization By similarity. Polyubiquitinated on Lys-278 through 'Lys-63'; the ubiquitination is mediated by NOD2 and RIPK2 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway. Polyubiquitinated on Lys-392 through 'Lys-63'; the ubiquitination is mediated by BCL10, MALT1 and TRAF6 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway. Monoubiquitinated on Lys-270 and Lys-302; promotes nuclear export. Polyubiquitinated through 'Lys-27' by TRIM23; involved in antiviral innate and inflammatory responses. Linear polyubiquitinated on Lys-111, Lys-143, Lys-226, Lys-246, Lys-270, Lys-278, Lys-285, Lys-295, Lys-302 and Lys-319; the head-to-tail polyubiquitination is mediated by the LUBAC complex and plays a key role in NF-kappa-B activation By similarity. Sumoylated on Lys-270 and Lys-302 with SUMO1; the modification results in phosphorylation of Ser-85 by ATM leading to a replacement of the sumoylation by mono-ubiquitination on these residues By similarity. Neddylated by TRIM40, resulting in stabilization of NFKBIA and down-regulation of NF-kappa-B activity By similarity. |
| Sequence similarities | Contains 1 C2HC-type zinc finger. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 412 | 412 | NF-kappa-B essential modulator | PRO_0000269197 | |||||
Regions | |||||||||
| Zinc finger | 389 – 410 | 22 | C2HC-type | ||||||
| Region | 44 – 111 | 68 | Interaction with CHUK/IKBKB By similarity | ||||||
| Region | 150 – 250 | 101 | Interaction with TANK By similarity | ||||||
| Region | 242 – 343 | 102 | Ubiquitin-binding (UBD) | ||||||
| Region | 246 – 358 | 113 | Self-association By similarity | ||||||
| Region | 249 – 412 | 164 | Required for interaction with TNFAIP3 By similarity | ||||||
| Region | 315 – 336 | 22 | Leucine-zipper Potential | ||||||
| Region | 375 – 412 | 38 | Interaction with CYLD By similarity | ||||||
| Coiled coil | 49 – 343 | 295 | Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 31 | 1 | Phosphoserine; by IKKB By similarity | ||||||
| Modified residue | 43 | 1 | Phosphoserine; by IKKB By similarity | ||||||
| Modified residue | 68 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 85 | 1 | Phosphoserine; by ATM By similarity | ||||||
| Modified residue | 369 | 1 | Phosphoserine; by IKKB By similarity | ||||||
| Disulfide bond | 54 | Interchain By similarity | |||||||
| Disulfide bond | 340 | Interchain By similarity | |||||||
| Cross-link | 111 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 139 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 143 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 226 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 246 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 270 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate By similarity | |||||||
| Cross-link | 270 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate By similarity | |||||||
| Cross-link | 276 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 278 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 285 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 295 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 302 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate By similarity | |||||||
| Cross-link | 302 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate By similarity | |||||||
| Cross-link | 314 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 319 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 392 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines." Saito N., Courtois G., Chiba A., Yamamoto N., Nitta T., Hironaka N., Rowe M., Yamamoto N., Yamaoka S. J. Biol. Chem. 278:46565-46575(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: Fischer 344. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AY392762 mRNA. Translation: AAQ94056.1. |
| IPI | IPI00400576. |
| RefSeq | NP_954534.1. NM_199103.1. |
| UniGene | Rn.214715. |
3D structure databases | |
| ProteinModelPortal | Q6TMG5. |
| SMR | Q6TMG5. Positions 49-109, 193-248, 387-412. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 10116.ENSRNOP00000053114. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSRNOT00000056275; ENSRNOP00000053114; ENSRNOG00000037237. |
| GeneID | 309295. |
| KEGG | rno:309295. |
Organism-specific databases | |
| CTD | 8517. |
| RGD | 735223. Ikbkg. |
Phylogenomic databases | |
| eggNOG | NOG138369. |
| GeneTree | ENSGT00530000063808. |
| HOGENOM | HOG000293233. |
| HOVERGEN | HBG000417. |
| InParanoid | Q6TMG5. |
| KO | K07210. |
| OrthoDB | EOG42BX8V. |
Gene expression databases | |
| ArrayExpress | Q6TMG5. |
| Genevestigator | Q6TMG5. |
Family and domain databases | |
| InterPro | IPR021063. NEMO_N. [Graphical view] |
| Pfam | PF11577. NEMO. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 660548. |
Entry information
| Entry name | NEMO_RAT | ||||||||
| Accession | Primary (citable) accession number: Q6TMG5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| SIMILARITY comments Index of protein domains and families |

Clusters with
